UnitedHealth [UNH] vs Centene [CNC] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: UnitedHealth wins in 11 metrics, Centene wins in 7 metrics, with 0 ties. UnitedHealth appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricUnitedHealthCenteneBetter
P/E Ratio (TTM)14.958.46Centene
Price-to-Book Ratio3.300.63Centene
Debt-to-Equity Ratio75.5863.91Centene
PEG Ratio-0.84-0.07UnitedHealth
EV/EBITDA11.023.71Centene
Profit Margin (TTM)5.04%1.29%UnitedHealth
Operating Margin (TTM)4.61%-0.95%UnitedHealth
EBITDA Margin (TTM)4.61%N/AN/A
Return on Equity21.65%7.44%UnitedHealth
Return on Assets (TTM)6.46%2.59%UnitedHealth
Free Cash Flow (TTM)$20.71B$-490.00MUnitedHealth
Dividend Yield2.05%N/AN/A
1-Year Return-40.17%-48.92%UnitedHealth
Price-to-Sales Ratio (TTM)0.740.11Centene
Enterprise Value$369.96B$17.69BUnitedHealth
EV/Revenue Ratio0.880.11Centene
Gross Profit Margin (TTM)17.93%6.05%UnitedHealth
Revenue per Share (TTM)$462$317UnitedHealth
Earnings per Share (Diluted)$23.10$4.16UnitedHealth
Beta (Stock Volatility)0.450.44Centene
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

UnitedHealth vs Centene Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
UnitedHealth1.56%2.36%14.55%15.01%-32.39%-29.89%
Centene3.02%7.07%24.31%9.00%-39.37%-39.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
UnitedHealth-40.17%-29.94%7.89%196.57%929.75%527.50%
Centene-48.92%-50.79%-42.65%28.43%526.19%556.33%

News Based Sentiment: UnitedHealth vs Centene

UnitedHealth

News based Sentiment: MIXED

October was a mixed month for UnitedHealth Group, marked by both strategic expansion of Medicare Advantage plans and difficult decisions to withdraw from certain markets due to funding cuts. While the company is investing in innovation and maintaining a positive long-term outlook, near-term financial challenges are evident, creating a mixed investment narrative.

View UnitedHealth News Sentiment Analysis

Centene

News based Sentiment: MIXED

October brought a mix of positive and neutral signals for Centene. While Cantor Fitzgerald maintained a neutral rating, positive earnings guidance, favorable regulatory changes, and increased institutional investment suggest a potential shift in investor sentiment and a possible recovery after a challenging period. The importance of Medicaid enrollment data adds a layer of complexity.

View Centene News Sentiment Analysis

Performance & Financial Health Analysis: UnitedHealth vs Centene

MetricUNHCNC
Market Information
Market Cap i$321.15B$17.42B
Market Cap CategoryMega capLarge cap
10 Day Avg. Volume i9,297,82011,995,180
90 Day Avg. Volume i13,353,52013,729,857
Last Close$353.72$36.82
52 Week Range$234.60 - $630.73$25.08 - $73.82
% from 52W High-43.92%-50.12%
All-Time High$630.73 (Nov 11, 2024)$98.53 (Aug 15, 2022)
% from All-Time High-43.92%-62.63%
Growth Metrics
Quarterly Revenue Growth0.13%0.17%
Quarterly Earnings Growth-0.19%0.22%
Financial Health
Profit Margin (TTM) i0.05%0.01%
Operating Margin (TTM) i0.05%-0.01%
Return on Equity (TTM) i0.22%0.07%
Debt to Equity (MRQ) i75.5863.91
Cash & Liquidity
Book Value per Share (MRQ)$104.67$55.80
Cash per Share (MRQ)$35.36$35.19
Operating Cash Flow (TTM) i$28.96B$1.73B
Levered Free Cash Flow (TTM) i$27.21B$1.61B
Dividends
Last 12-Month Dividend Yield i2.05%N/A
Last 12-Month Dividend i$6.30N/A

Valuation & Enterprise Metrics Analysis: UnitedHealth vs Centene

MetricUNHCNC
Price Ratios
P/E Ratio (TTM) i14.958.46
Forward P/E i11.555.00
PEG Ratio i-0.84-0.07
Price to Sales (TTM) i0.740.11
Price to Book (MRQ) i3.300.63
Market Capitalization
Market Capitalization i$321.15B$17.42B
Enterprise Value i$369.96B$17.69B
Enterprise Value Metrics
Enterprise to Revenue i0.880.11
Enterprise to EBITDA i11.023.71
Risk & Other Metrics
Beta i0.450.44
Book Value per Share (MRQ) i$104.67$55.80

Financial Statements Comparison: UnitedHealth vs Centene

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)UNHCNC
Revenue/Sales i$111.62B$46.62B
Cost of Goods Sold i$91.60B$41.42B
Gross Profit i$20.01B$5.20B
Research & Development iN/AN/A
Operating Income (EBIT) i$5.15B$1.53B
EBITDA i$6.23B$1.85B
Pre-Tax Income i$4.08B$1.75B
Income Tax i$510.00M$432.00M
Net Income (Profit) i$3.57B$1.31B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)UNHCNC
Cash & Equivalents i$30.72B$14.82B
Total Current Assets i$96.29B$41.29B
Total Current Liabilities i$113.47B$37.14B
Long-Term Debt i$71.29B$18.31B
Total Shareholders Equity i$105.17B$28.02B
Retained Earnings i$97.93B$16.66B
Property, Plant & Equipment iN/AN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)UNHCNC
Operating Cash Flow i$2.45B$937.00M
Capital Expenditures i$-898.00MN/A
Free Cash Flow i$4.56B$1.38B
Debt Repayment i$0$-958.00M
Common Stock Repurchase i$-3.00B$-41.00M

Short Interest & Institutional Ownership Analysis

MetricUNHCNC
Shares Short i14.24M19.58M
Short Ratio i0.741.32
Short % of Float i0.02%0.05%
Average Daily Volume (10 Day) i9,297,82011,995,180
Average Daily Volume (90 Day) i13,353,52013,729,857
Shares Outstanding i915.00M495.91M
Float Shares i897.82M462.35M
% Held by Insiders i0.01%0.00%
% Held by Institutions i0.87%0.99%

Dividend Analysis & Yield Comparison: UnitedHealth vs Centene

MetricUNHCNC
Last 12-Month Dividend i$6.30N/A
Last 12-Month Dividend Yield i2.05%N/A
3-Year Avg Annual Dividend i$6.33N/A
3-Year Avg Dividend Yield i0.38%N/A
3-Year Total Dividends i$18.99N/A
Ex-Dividend DateMar 10, 2025N/A